Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StockFreak.com Presents Volume Reports on CNDO, BZNE, HSCO, and OPK

OPK, HSCO

Whether you are bull or bear, Stock Freak has got you covered and will help you stay up to date on stocks on the run. Take a few minutes to register with us free at http://www.stockfreak.com/ to get exclusive access to all of our free stock reports.

Coronado Biosciences, Inc. (NASDAQ: CNDO) shares fell 66.90 percent to close at $1.91 a share on Monday. The stock traded between $1.73 and $2.16 on volume of a little over 26 million shares. $1.73 represented a new 52-week low for the stock. The big fall came after the Company said its experimental Crohn's disease treatment using eggs from a parasitic worm failed in a mid-stage clinical trial.

Get more information on Coronado Biosciences, Inc. and free access to the in-depth equity report at: http://www.StockFreak.com/stockquote/CNDO

Biozone Pharmaceuticals, Inc. (OTCBB: BZNE) shares saw an unusual breakout on Monday and closed up 7.84 percent. The stock traded about 2.7 million shares. The Company was featured in an article on The Street last Friday. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.

Get more information on Biozone Pharmaceuticals, Inc. and free access to the in-depth equity report at: http://www.StockFreak.com/stockquote/BZNE

Hi Score Corporation (OTC: HSCO) shares experienced an unusual plunge, closing down 96.63 percent on Monday. The stock hit a new 52-week low of $0.0013 and closed at $0.0017 on a little over 83 million shares traded. Hi Score Corporation, through its subsidiaries, supplies light emitting diode specialty light bulbs in the United States.

Get more information on Hi Score Corporation and free access to the in-depth equity report at: http://www.StockFreak.com/stockquote/HSCO

Opko Health, Inc. (NYSE: OPK) shares closed up 8.34 percent on Monday. The stock traded between $9.97 and $10.95 that day with a little over 6 million shares traded. The stock was featured yesterday in an alert on The Street.

Get more information on Opko Health, Inc. and free access to the in-depth equity report at:
http://www.StockFreak.com/stockquote/OPK

Disclosure: StockFreak.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always visit our website, for complete risks and disclosures.